Newsletter Subject

Mind of the 'Maestro': Inside the Head of Leonard Bernstein

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, Dec 30, 2023 12:16 PM

Email Preheader Text

Weekly Review Saturday, December 30, 2023 THE BREAK ROOM CME SPOTLIGHT THE BREAK ROOM ADVERTISEMENT

[MEDPAGE TODAY]( Weekly Review Saturday, December 30, 2023 [Mind of the 'Maestro': Inside the Head of Leonard Bernstein]( [Young-Onset Dementia Tied to New Risk Factors]( [Dangerous Brazilian Butt Lifts Get a Makeover in Florida]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Unlocking the Power of PARP Inhibition in Metastatic Castration-Resistant Prostate Cancer]( [Do You Believe in These Medical Superstitions?]( [Food as Diabetes Medicine? Maybe Not, Trial Suggests]( THE BREAK ROOM [Play Today's Wordosis: Our Medical Word Game]( ADVERTISEMENT [A New Test Could Save Arthritis Patients Time, Money, and Pain]( CME SPOTLIGHT [Leveraging the Multidisciplinary Team to Improve Lung Cancer Care]( [FDA Warns Amazon Over Supplements Containing Erectile Dysfunction Drugs]( [Deep Flaws in FDA's Device Oversight, and Patient Harm, Exposed in Lawsuits, Records]( [Supreme Court to Weigh in on Abortion Pill Access]( CME SPOTLIGHT [Advancing AML Care: A Targeted Approach]( [Midlife Alzheimer's Biomarker; How Measles Spread in the Brain; MS and HIV]( [Brain Impairment Persists at Least 18 Months After COVID Hospitalization]( [Another CAR-T Warning; 'Sweet' Cancer Test; 'Molecular Jackhammer' Blows Up Cancer]( CME SPOTLIGHT [PARP Prodigy: Mastering Metastatic Castration-Resistant Prostate Cancer]( [Medicare Cuts Beg the Question: Do Doctors Know How to Make 'Good Trouble'?]( [Patients Are Lucky Cigna Dropped Its Plans to Buy Humana]( [Autism Aggression Sensor; Psychiatry Top Telehealth Spender; Mid-Stage Wins, Losses]( CME SPOTLIGHT [Integrating Biomarkers and Guideline-Aligned Treatment Approaches Into Patient-Centered Care for Advanced/Metastatic Endometrial Cancer]( [Can Residents Flourish? Managing Common Foot and Ankle Conditions]( [Prenatal Fentanyl Exposure Suspected in Novel Syndrome]( [Pediatric RSV Led to Higher Hospitalization Rates Than Omicron or Flu]( CME SPOTLIGHT [Emerging Clinical Efficacy and Safety Data in Recurrent and Metastatic Cervical Cancer]( [DAPT Stays Helpful for Minor Stroke Even With Later Presentation, Worse Symptoms]( [Nuclear Tracer Shortage; Weighing Post-Ablation OAC; Fix for Biased AI Tools?]( [Hibernating Squirrels for Obesity? Dialysis Warning; Endocrinology and Telehealth]( CME SPOTLIGHT [Managing Adverse Events and Patient-Centered Care in Recurrent and Metastatic Cervical Cancer]( [Hospital Complications Rise After Private Equity Buyout]( [It Was a Tumultuous Year for Simone Gold and America's Frontline Doctors]( [On the Health Docket for the Supreme Court's 2024 Term]( CME SPOTLIGHT [Patient-Centered Care for Gastric Cancer: Utilizing an Interdisciplinary Approach to Improve Outcomes]( [Kindness Doesn't Have a Billable Code]( [Here's How Common Long COVID Is in Children]( [Testosterone for Hypogonadism Cleared So Far of Prostate Cancer Risk]( ['If You Want Your Stocking Stuffed on Christmas, Go Ahead': What We Heard This Week]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_DHE_Weekly?xid=nl_mpt_DHE_2023-12-30&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

13/05/2024

Sent On

12/05/2024

Sent On

12/05/2024

Sent On

11/05/2024

Sent On

10/05/2024

Sent On

10/05/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.